eviplera

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AR - Combinations -> J05AR08 - Eviplera
Administration category: Free Medicine group: antiviral Brand name: Eviplera

Standard dosages

≥ 18 years
WeightROALoadDosage
ROA:
po
Load:
-
Dosage:
1pieces 1 dd

Kidney function

≥ 18 years
ROAGFRDosageIntervalComments
ROA: po
GFR:
30 - 50
Dosage:
do not prescribe
GFR:
<30
Dosage:
do not prescribe
Renal elimination: tenofovir: 70-80%, emtricitabine: 86%, rilpivirine: 6%
Dosage: dependent on kidney function

Renal function-replacement therapy

CAPD: vermijd gebruik van het combinatiepreparaat

Hemo dialysis: vermijd gebruik van het combinatiepreparaat

CAV / VVHD: vermijd gebruik van het combinatiepreparaat

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.

Comments

1 tablet 1 dd p.o.: bevat tenofovirdisoproxil (als fumaraat) 245 mg, emtricitabine 200 mg, rilpivirine (als hydrochloride) 25 mg

Metadata

Swab vid: M-2964.2
Updated: 06/16/2019 - 20:05
Status: Published

External links
Menu position